More on AUTL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)
- Holders

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Autolus Therapeutics (NQ:AUTL)
Delayed: 2.31 -0.04 (1.7%)
Prev. Close $2.35  
Open$2.31 
52 Wk High$ 
52 Wk Low$ 
Day High$2.38 
Day Low$2.30 
P/E N/A  
EPS$ 
Volume1,477,707 

Friends, Peers and Foes (?): A, AVBP, IPH, IPHA, 0A3M (more...)

Aug 28, 2026 09:08 PM Form SCHEDULE 13D/A Autolus Therapeutics Filed by: PPF Group a.s.
Aug 14, 2026 10:02 AM Form SCHEDULE 13G/A Autolus Therapeutics Filed by: ARMISTICE CAPITAL, LLC
Aug 11, 2026 04:15 PM Form 10-Q Autolus Therapeutics For: Jun 30
Aug 11, 2026 07:34 AM Form 8-K Autolus Therapeutics For: Aug 11
Aug 11, 2026 07:16 AM Autolus Therapeutics (AUTL) Tops Q2 EPS by 8c
Aug 11, 2026 07:00 AM Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
Aug 3, 2026 04:05 PM Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026
Aug 3, 2026 08:11 AM Form 8-K Autolus Therapeutics For: Aug 03
Aug 3, 2026 07:13 AM Autolus raises guidance, secures $250M credit facility with Perceptive
Aug 3, 2026 07:13 AM Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
View All Articles

Entities mentioned with AUTL

View All Entities